| 5LZ2: reference: Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)., Woolford AJ, Day PJ, Beneton V, Berdini V, Coyle JE, Dudit Y, Grondin P, Huet P, Lee LY, Manas ES, McMenamin RL, Murray CW, Page LW, Patel VK, Potvain F, Rich SJ, Sang Y, Somers DO, Trottet L, Wan Z, Zhang X, J Med Chem. 2016 Dec 8;59(23):10738-10749. Epub 2016 Nov 18. PMID: 27933945 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).